IM Cannabis Corp. (IMCC) vs China SXT Pharmaceuticals, Inc. (SXTC)

IM Cannabis Corp. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. China SXT Pharmaceuticals, Inc. is the larger, with a market value of $2.0M against $980.0K — 2.1× the size. IM Cannabis Corp. grew revenue faster over the last twelve months: −12.0% against −54.0%. IM Cannabis Corp. has the higher net margin (−38.9% vs −255.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, IM Cannabis Corp. leads on 8 and China SXT Pharmaceuticals, Inc. on 8.

Valuation

Metric IMCC SXTC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.01 n/m 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 0.01 2.66 12.22
EV/Sales 0.00 (5.94) 2.87
Earnings yield (13,047.81%) (3,722.74%) (15.94%)
Free cash flow yield (267.31%) 0.00% 0.00%

Profitability

Metric IMCC SXTC Drug Manufacturers Specialty & Generic median
Gross margin 12.62% 36.69% 53.51%
Operating margin (32.88%) 0.00% 0.00%
Net margin (38.92%) (255.16%) (2.45%)
Free cash flow margin (1.47%) 0.00% 0.00%
Return on equity 2,280.06% 0.00% (0.80%)
Return on assets (54.20%) 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMCC SXTC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (11.97%) (53.98%) 5.22%
EPS growth (last fiscal year) 41.95% (162.25%) 42.91%
Revenue growth, 5-year CAGR 26.99% (24.94%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMCC SXTC Drug Manufacturers Specialty & Generic median
Debt to equity (0.12) 0.03 0.04
Current ratio 0.56 7.94 2.41
Net debt to EBITDA 0.18 3.86 1.01

Dividend

Metric IMCC SXTC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric IMCC SXTC Drug Manufacturers Specialty & Generic median
Market cap 980.00k 2.02m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack